CD82 and prostate carcinoma: Notably, the EMT degrees in those parental cell lines, as well as the stable transfectant clones with different CD82 levels, appeared to be inversely correlated with CD82 expression levels, implicating that decrease or loss of CD82 expression renders prostate cancer cells prone to undergoing EMT.